IHAM
AVTX icon

Integral Health Asset Management’s Avalo Therapeutics AVTX Stock Holding History

Integral Health Asset Management’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-243
Closed -$507K – 68
2022
Q1 		$507K Sell
243
-321
-57% -$806K 0.13% 70
2021
Q4 		$2.76M Hold
564
– – 0.77% 42
2021
Q3 		$3.54M Buy
564
+330
+141% +$2.67M 1.02% 41
2021
Q2 		$2.21M Buy
234
+26
+13% +$218K 0.61% 48
2021
Q1 		$1.81M Buy
+208
New +$1.97M 0.52% 54

Other funds holding AVTX

NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return